The contract development and manufacturing organization (CDMO), Patheon has acquired Gallus Biopharmaceuticals, which has two mammalian cell culture facilities in the US. In particular, the St. Louis, Missouri plant, is a site that has served some very big pharmaceutical companies. It also uses industrial stainless steel and single-use equipment. Patheon may look at additional acquisitions in the future but for the time being will look fully integrating Gallus.